1. | asheymommy | |
2. | marz11 | |
3. | dynamichealthsol | |
4. | franciscaguila78 | |
5. | badaleyes |
1. | asheymommy | |
2. | marz11 | |
3. | dynamichealthsol | |
4. | franciscaguila78 | |
5. | badaleyes |
1. | dynamichealthsol 02/02/2018 Beats EPS estimates by $0.04. |
2. | badaleyes 02/02/2018 Big news - Sees FY18 revs $41.2-42.7 bln vs $41.10 bln |
3. | asheymommy 01/26/2018 today > $MRK - CHMP gave positive opinions for three medicines to treat type 2 diabetes: Segluromet (ertugliflozin / metform… |
4. | asheymommy 03/01/2018 News |
5. | franciscaguila78 05/04/2018 Moderna and Merck Expand mRNA Cancer Vaccines Collaboration |
6. | dynamichealthsol 01/03/2018 er details |
7. | marz11 04/10/2018 Merck monotherapy met primary endpoint in phase 3 keynote-042 study, significantly improving OS as first-line… |
8. | badaleyes 05/03/2018 Merck Phase 3 KEYNOTE-407 trial investigating KEYTRUDA meets secondary endpoint |
9. | franciscaguila78 06/25/2018 FDA accepts supplemental biologics license application for Merck’s KEYTRUDA |
10. | marz11 06/25/2018 Presents new data for Sitagliptin Program with JANUVIA |